SEC Form 4 · accession 0001127602-17-009745
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eva C Boratto
Officer — SVP, Cont & Chief Acct Officer
Period of report
Feb 28, 2017
Accepted (ET)
Mar 2, 2017 · 4:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock (restricted)F1 | Feb 28, 2017 | A | 1,385 | $80.58 | A | 16,831 | D | |
| Common StockF2 | Feb 28, 2017 | A | 2,482 | $80.58 | A | 36,413 | D | |
| Common StockF3 | Feb 28, 2017 | F | 828 | $80.58 | D | 35,585 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan and its Performance-Based Restricted Stock Unit Plan. Restrictions lapse in three equal installments, commencing February 28, 2018.
- F2Consists of stock awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan.
- F3Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Registrant's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan.